Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias

Clin Neuropharmacol. 2007 Mar-Apr;30(2):122-4. doi: 10.1097/wnf.0b013e318033a6c7.
No abstract available

Publication types

  • Evaluation Study
  • Letter

MeSH terms

  • Aged
  • Antiparkinson Agents / adverse effects
  • Drug Administration Schedule
  • Dyskinesia, Drug-Induced / blood
  • Dyskinesia, Drug-Induced / drug therapy*
  • Dyskinesia, Drug-Induced / etiology
  • Female
  • Humans
  • Levetiracetam
  • Levodopa / adverse effects
  • Levodopa / blood
  • Male
  • Middle Aged
  • Nootropic Agents / pharmacokinetics*
  • Nootropic Agents / therapeutic use*
  • Parkinson Disease / blood
  • Parkinson Disease / drug therapy*
  • Piracetam / analogs & derivatives*
  • Piracetam / pharmacokinetics
  • Piracetam / therapeutic use
  • Statistics, Nonparametric

Substances

  • Antiparkinson Agents
  • Nootropic Agents
  • Levetiracetam
  • Levodopa
  • Piracetam